Gland Pharma Limited announced that at its board Meeting held on March 10, 2022 approved appointment of Mr. Yao Fang as an Additional Director, categorized as Non-Independent and Non-Executive Director, with effect from March 10, 2022 as a Director liable to retire by rotation and resignation of Mr. Li Dongming with effect from the conclusion of Board Meeting on March 10, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,874 INR | -0.10% | +2.21% | -2.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.64% | 3.69B | |
+48.53% | 780B | |
+41.80% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+17.94% | 244B | |
-1.06% | 217B | |
+11.45% | 214B | |
+4.40% | 161B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Gland Pharma Limited Announces Executive Changes